Overview
Status
Active
Registry date
2011-12-20
Share capital
5 000,00 PLN
Registered address
ul. Ludwika Narbutta 46/48, 02-541 Warszawa, Poland
Website
podos.plWebsite active
Electronic delivery address
AE:PL-72702-55185-CFECS-19
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 4.35mMedianUSD 424.39kAverageUSD 1.68m
Net profit
This companyUSD 200.93kMedianUSD 13.22kAverageUSD 129.69k
Operating costs
This companyUSD 3.94mMedianUSD 377.30kAverageUSD 1.50m
Assets
This companyUSD 1.21mMedianUSD 168.66kAverageUSD 1.47m
Industry
Bank accounts
Registered as a VAT taxpayer on 2012-05-11. Active
27 1050 1025 1000 0090 8306 9030
40 1050 1025 1000 0090 8068 9095
62 1050 1025 1000 0090 8068 9087
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
5 public aid cases recorded, with a total value of $649,066.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 15, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $24,108$24,108 | Prezes Banku Gospodarstwa Krajowego | |
| Dec 5, 2024 | Aid for research and development projects: experimental development | $326.3K$326,322 | Prezes Agencji Badań Medycznych | |
| Dec 5, 2024 | Aid for research and development projects: industrial research | $263.5K$263,533 | Prezes Agencji Badań Medycznych |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Arkadiusz Tadeusz Krakowiecki – Management Board Member
Paweł Galicki – President of the Management Board
Marcin Malka – Management Board Member
Manner of representation
Two members of the management board jointly, or one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Podos Przychodnia Lekarsko-podologiczna Sp. z o.o. | 50 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Bodyclinicsp. z o.o. + limited partnership | $3,798,674.65 | bodyclinic.pl | ||
| Zakład Medyczny Kaar-Med Outsourcingsp. z o.o. + limited partnership | $3,654,198.53 | kaarmed.pl | ||
| Mega-Lenssp. z o.o. | $3,290,632.61 | megalens.pl | ||
| Mediqpolsp. z o.o. | $2,775,865.98 | mediqpol.pl | ||
| Quadiasp. z o.o. + limited partnership | $2,151,119.92 | quadia.pl | ||
| CM Woroniczasp. z o.o. | $1,357,667.63 | cmworonicza.pl | ||
| Kolmed Kompleksowa Obsługa Medycznasp. z o.o. | $1,314,850.36 | kolmed.pl | ||
| Aktimedicasp. z o.o. | $1,151,238.49 | fitmedica.pl | ||
| Neurospherasp. z o.o. | $1,108,640.71 | neurosphera.pl | ||
| Prime Clinicsp. z o.o. | $1,054,452.54 | primeclinic.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-12-12 | Name change (Podema → Podos Klinika Leczenia Ran) | |
| 2017-03-15 | Address change (Ul. Władysława Trylińskiego 2/105, 10-683, Olsztyn → Ul. Ludwika Narbutta 46/48, 02-541, Warszawa) | |
| 2015-10-19 | Address change (Ludwika Narbutta 46-48, 02-541, Warszawa → Ul. Władysława Trylińskiego 2/105, 10-683, Olsztyn) | |
| 2015-10-19 | PKD change (Removed: 58.11.Z, 58.13.Z, 58.14.Z, 58.19.Z, 63.91.Z, 63.99.Z, 77.39.Z, 86.10.Z) | |
| 2012-03-26 | Address change (Aleja Waszyngtona 41/18, 04-015, Warszawa → Ludwika Narbutta 46-48, 02-541, Warszawa) |
FAQ
The main business activity of Podos Klinika Leczenia Ran focuses on specialist medical practice activities.
The company was registered in the Polish National Court Register (KRS) on December 20, 2011.
The headquarters is located at: ul. Ludwika Narbutta 46/48, 02-541 Warszawa.
The management board includes: Arkadiusz Tadeusz Krakowiecki (Member of the Management Board) and Marcin Malka (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $3,416,841 in 2024, which is an increase of 92.8% compared to 2023.
Yes, in 2024 the company was profitable, achieving a net profit of $101,873, meaning the company increased its profit by 121.7%.
The largest operating cost category falls under external services. This category amounted to $1,198,203 in 2024, representing 37% of all operating expenses.
Last updated: 2026-10-07